SYN-TECH Chem. & Pharm. Co., Ltd. (TPEX:1777)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
75.30
+0.30 (0.40%)
At close: Jul 9, 2026
Market Cap3.36B -14.5%
Revenue (ttm)1.26B -3.3%
Net Income257.51M -32.5%
EPS5.75 -32.7%
Shares Out 44.59M
PE Ratio13.10
Forward PEn/a
Dividend4.00 (5.33%)
Ex-Dividend DateJul 16, 2026
Volume88,367
Open75.00
Previous Close75.00
Day's Range74.80 - 75.60
52-Week Range70.00 - 86.20
Beta-0.06
Analystsn/a
Price Targetn/a
Earnings DateAug 6, 2026

About SYN-TECH Chem. & Pharm.

SYN-TECH Chem. & Pharm. Co., Ltd. manufactures and sells active pharmaceutical ingredients (APIs) in Taiwan, Asia, Europe, the Americas, and internationally. The company offers test drugs and surfactants, as well as various Chinese, Western, and animal medicines. It also provides products in various categories, such as anticoagulant, attention deficit hyperactivity disorder, skeletal muscle relaxant, antitussive, antipruritic, scabicide, anti-inflammatory, antipyretic, analgesic, muscle relaxant, anxiolytic, antiemetic, anticonvulsant, anti-ulc... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1982
Employees 223
Stock Exchange Taipei Exchange
Ticker Symbol 1777
Full Company Profile

Financial Performance

In 2025, SYN-TECH Chem. & Pharm.'s revenue was 1.30 billion, an increase of 3.39% compared to the previous year's 1.26 billion. Earnings were 261.61 million, a decrease of -33.48%.

Financial Statements